Naleya Genomik Indonesia (NGI) is a biotechnology company driving the future of precision health in Indonesia.
As one of the country’s leading genomics laboratories, we provide high-quality, affordable, and clinically actionable genetic testing in reproductive health, rare diseases, and inherited conditions - powered by advanced infrastructure and international technology transfer.
We collaborate with hospitals, government institutions, and academic partners to localize cutting-edge biotechnology, accelerate clinical adoption, and support Indonesia’s national healthcare transformation.
NGI is building a robust, scalable, and trusted genomics ecosystem - from clinic to community - with a mission to make precision healthcare accessible, sustainable, and impactful for all Indonesians.
From Indonesia. By Indonesia. For Indonesia.
Company Details
- Employees
- 26
- Founded
- 2022
- Address
- Jalan Tb Simatupang, Wisma Mra 18th Floor,indonesia
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.naleya-genomics.com
- HQ
- Cilandak Barat, Jakarta
Naleya Genomics (Ngi) Questions
Naleya Genomics (Ngi)'s website is http://www.naleya-genomics.com
Naleya Genomics (Ngi)'s LinkedIn profile is https://id.linkedin.com/company/naleya-genomics
Naleya Genomics (Ngi) has
26 employees.
View email and phone details for 26
employees at Naleya Genomics (Ngi).
Naleya Genomics (Ngi)'s industry is
Biotechnology Research
Naleya Genomics (Ngi)'s top competitors are
Bumame,
Nalagenetics,
Mgi,
Nusantics,
Biomedical And Genomic Science Initiatives,
Biosm Indonesia - Biotechnology Solution,
Pt Etana Biotechnologies Indonesia,
Bgi Genomics,
Tanyadna By Gsi,
Genetics Indonesia.
Naleya Genomics (Ngi)'s categories are Biotechnology Research
Naleya Genomics (Ngi)'s founding year is 2022
